| For: | Tack GJ, van de Water JM, Bruins MJ, Kooy-Winkelaar EM, van Bergen J, Bonnet P, Vreugdenhil AC, Korponay-Szabo I, Edens L, von Blomberg BME, Schreurs MW, Mulder CJ, Koning F. Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study. World J Gastroenterol 2013; 19(35): 5837-5847 [PMID: 24124328 DOI: 10.3748/wjg.v19.i35.5837] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i35/5837.htm |
| Number | Citing Articles |
| 1 |
Nicole Mika, Holger Zorn, Martin Rühl. Prolyl-specific peptidases for applications in food protein hydrolysis. Applied Microbiology and Biotechnology 2015; 99(19) doi: 10.1007/s00253-015-6838-0
|
| 2 |
Valli De Re, Raffaella Magris, Renato Cannizzaro. New Insights into the Pathogenesis of Celiac Disease. Frontiers in Medicine 2017; 4 doi: 10.3389/fmed.2017.00137
|
| 3 |
Antonio Di Sabatino, Marco Vincenzo Lenti, Paolo Giuffrida, Alessandro Vanoli, Gino Roberto Corazza. New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract. Autoimmunity Reviews 2015; 14(12) doi: 10.1016/j.autrev.2015.08.004
|
| 4 |
Justin L McCarville, Alberto Caminero, Elena F Verdu. Pharmacological approaches in celiac disease. Current Opinion in Pharmacology 2015; 25 doi: 10.1016/j.coph.2015.09.002
|
| 5 |
Philipp Lapuhs, Gregor Fuhrmann. Therapeutic Enzymes: Function and Clinical Implications. Advances in Experimental Medicine and Biology 2019; 1148 doi: 10.1007/978-981-13-7709-9_8
|
| 6 |
Kalle Kurppa, Minna Hietikko, Ana-Marija Sulic, Katri Kaukinen, Katri Lindfors. Current status of drugs in development for celiac disease. Expert Opinion on Investigational Drugs 2014; 23(8) doi: 10.1517/13543784.2014.916274
|
| 7 |
Julia König, Savanne Holster, Maaike J. Bruins, Robert J. Brummer. Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-13587-7
|
| 8 |
Michael Klonarakis, Christopher N. Andrews, Maitreyi Raman, Remo Panaccione, Christopher Ma. Review article: therapeutic targets for the pharmacologic management of coeliac disease—the future beyond a gluten‐free diet. Alimentary Pharmacology & Therapeutics 2022; 55(10) doi: 10.1111/apt.16846
|
| 9 |
Harrison A. Besser, Chaitan Khosla. Celiac disease: mechanisms and emerging therapeutics. Trends in Pharmacological Sciences 2023; 44(12) doi: 10.1016/j.tips.2023.09.006
|
| 10 |
Juan Pablo Stefanolo, Verónica Segura, Martina Grizzuti, Abel Heredia, Isabel Comino, Ana Florencia Costa, Roberto Puebla, María Paz Temprano, Sonia Isabel Niveloni, Gabriel de Diego, María E Oregui, Edgardo Gustavo Smecuol, Mauricio C de Marzi, Elena F Verdú, Carolina Sousa, Julio César Bai. Effect of <i>Aspergillus niger</i> prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet. World Journal of Gastroenterology 2024; 30(11): 1545-1555 doi: 10.3748/wjg.v30.i11.1545
|
| 11 |
Nicholas M. Plugis, Chaitan Khosla. Therapeutic approaches for celiac disease. Best Practice & Research Clinical Gastroenterology 2015; 29(3) doi: 10.1016/j.bpg.2015.04.005
|
| 12 |
Carmen Gianfrani, Serena Vitale, Riccardo Troncone. Advances in Celiac Disease. 2022; doi: 10.1007/978-3-030-82401-3_13
|
| 13 |
Tjaard Pijning, Andreja Vujičić‐Žagar, Jan‐Metske van der Laan, René M. de Jong, Carlos Ramirez‐Palacios, Andre Vente, Luppo Edens, Bauke W. Dijkstra. Structural and time‐resolved mechanistic investigations of protein hydrolysis by the acidic proline‐specific endoprotease from Aspergillus niger. Protein Science 2024; 33(1) doi: 10.1002/pro.4856
|
| 14 |
Roxana Nemteanu, Irina Ciortescu, Corina Elena Hincu, Andreea Clim, Liliana Gheorghe, Anca Trifan, Alina Plesa. Replacing the Burden of the Gluten Free Diet: Then, Now, and the Future. International Journal of Molecular Sciences 2022; 23(23) doi: 10.3390/ijms232315108
|
| 15 |
Šárka O. Southern, Mark A. Mentzer, Isaac Rodriguez-Chavez, Virginia E. Wotring, Eva J. Helmerhorst, Guoxian Wei. Experimental strategy to discover microbes with gluten-degrading enzyme activities. Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV 2014; 9112 doi: 10.1117/12.2058730
|
| 16 |
Marina Girbal-González, Arturo Rodríguez-Banqueri, Hadeel Swaid, Soraia R Mendes, Laura Garzón-Flores, Juan Sebastián Ramírez-Larrota, Carolina Cueva, M Victoria Moreno-Arribas, Christof Regl, Christian G Huber, Katharina A Scherf, María José Rodríguez-Lagunas, Àngels Franch-Masferrer, Ulrich Eckhard, Francisco J Pérez-Cano, F Xavier Gomis-Rüth. Targeted enzymatic therapy for coeliac disease. EMBO Molecular Medicine 2026; 18(6) doi: 10.1038/s44321-026-00430-8
|
| 17 |
Dominique Turck, Jean‐Louis Bresson, Barbara Burlingame, Tara Dean, Susan Fairweather‐Tait, Marina Heinonen, Karen‐Ildico Hirsch‐Ernst, Inge Mangelsdorf, Harry J. McArdle, Androniki Naska, Monika Neuhäuser‐Berthold, Grażyna Nowicka, Kristina Pentieva, Yolanda Sanz, Alfonso Siani, Anders Sjödin, Martin Stern, Daniel Tomé, Marco Vinceti, Peter Willatts, Karl‐Heinz Engel, Rosangela Marchelli, Annette Pöting, Morten Poulsen, Josef Schlatter, Wolfgang Gelbmann, Henk Van Loveren. Safety of proline‐specific oligopeptidase as a novel food pursuant to Regulation (EC) No 258/97. EFSA Journal 2017; 15(2) doi: 10.2903/j.efsa.2017.4681
|
| 18 |
Marica Colella, Concetta Cafiero, Raffaele Palmirotta. <i>Aspergillus niger</i> prolyl endopeptidase in celiac disease. World Journal of Gastroenterology 2024; 30(24): 3044-3047 doi: 10.3748/wjg.v30.i24.3044
|
| 19 |
NEW PHARMACOLOGICAL THERAPIES FOR CELIAC DISEASE – A SYSTEMATIC REVIEW. International Journal of Innovative Technologies in Social Science 2025; 6(3(47)) doi: 10.31435/ijitss.3(47).2025.3846
|
| 20 |
Tessa Dieckman, Frits Koning, Gerd Bouma. Celiac disease: New therapies on the horizon. Current Opinion in Pharmacology 2022; 66 doi: 10.1016/j.coph.2022.102268
|
| 21 |
Joshua P. Taylor, Fritz Jacob, Emanuele Zannini, Elke K. Arendt. Reduction of Hordein Content in Beer by Applying Prolyl Endoprotease to the Malting Process. Journal of the American Society of Brewing Chemists 2017; 75(3) doi: 10.1094/ASBCJ-2017-3072-01
|
| 22 |
Karolina Kubala, Tomasz Pietrucha, Mikolaj Goldyn, Magdalena Grabinska, Paulina Halik, Justyna Jusiak. Integrated Role of Microbial, Fungal, and Plant-Derived Interventions in the Management of Celiac Disease: A Narrative Review. Cureus 2026; doi: 10.7759/cureus.102471
|
| 23 |
Marco Gobbetti, Erica Pontonio, Pasquale Filannino, Carlo Giuseppe Rizzello, Maria De Angelis, Raffaella Di Cagno. How to improve the gluten-free diet: The state of the art from a food science perspective. Food Research International 2018; 110 doi: 10.1016/j.foodres.2017.04.010
|
| 24 |
Julie Zhu, Chris J J Mulder, Levinus A Dieleman. Celiac Disease: Against the Grain in Gastroenterology. Journal of the Canadian Association of Gastroenterology 2019; 2(4) doi: 10.1093/jcag/gwy042
|
| 25 |
Amin Abbasi, Sara Bazzaz, Salam A. Ibrahim, Azita Hekmatdoost, Hedayat Hosseini, Sahar Sabahi, Elham Sheykhsaran, Yalda Rahbar Saadat, Mahdi Asghari Ozma, Masoud Lahouty. A Critical Review on the Gluten-Induced Enteropathy/Celiac Disease: Gluten-Targeted Dietary and Non-Dietary Therapeutic Approaches. Food Reviews International 2024; 40(3) doi: 10.1080/87559129.2023.2202405
|
| 26 |
Marek K. Kowalski, Danuta Domżał-Magrowska, Ewa Małecka-Wojciesko. Celiac Disease—Narrative Review on Progress in Celiac Disease. Foods 2025; 14(6) doi: 10.3390/foods14060959
|
| 27 |
Alberto Caminero, Elena F. Verdu, Heather J. Galipeau. Celiac Disease. Methods in Cell Biology 2023; 179 doi: 10.1016/bs.mcb.2023.01.017
|
| 28 |
Miguel Ángel López Casado, Pedro Lorite, Candelaria Ponce de León, Teresa Palomeque, Maria Isabel Torres. Celiac Disease Autoimmunity. Archivum Immunologiae et Therapiae Experimentalis 2018; 66(6) doi: 10.1007/s00005-018-0520-z
|
| 29 |
María de Lourdes Moreno, Verónica Segura, Ángela Ruiz-Carnicer, Ana María Nájar, Isabel Comino, Carolina Sousa. Biotechnological Strategies for the Treatment of Gluten Intolerance. 2021; doi: 10.1016/B978-0-12-821594-4.00005-0
|
| 30 |
Ingrid Swanson Pultz, Malcolm Hill, Joanne M. Vitanza, Clancey Wolf, Lasse Saaby, Tina Liu, Peter Winkle, Daniel A. Leffler. Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease. Gastroenterology 2021; 161(1) doi: 10.1053/j.gastro.2021.03.019
|
| 31 |
Yakov E. Dunaevsky, Valeriia F. Tereshchenkova, Mikhail A. Belozersky, Irina Y. Filippova, Brenda Oppert, Elena N. Elpidina. Effective Degradation of Gluten and Its Fragments by Gluten-Specific Peptidases: A Review on Application for the Treatment of Patients with Gluten Sensitivity. Pharmaceutics 2021; 13(10) doi: 10.3390/pharmaceutics13101603
|
| 32 |
Hugh James Freeman. Emerging drugs for celiac disease. Expert Opinion on Emerging Drugs 2015; 20(1) doi: 10.1517/14728214.2015.985204
|
| 33 |
Simona Gatti, Matilde Rossi, Simona Alfonsi, Alessandra Mandolesi, Giovanni Cobellis, Carlo Catassi. Beyond the Intestinal Celiac Mucosa: Diagnostic Role of Anti-TG2 Deposits, a Systematic Review. Frontiers in Medicine 2014; 1 doi: 10.3389/fmed.2014.00009
|
| 34 |
Antonella Santonicola, Carlo Soldaini, Carolina Ciacci. New therapies in celiac disease. Current Opinion in Gastroenterology 2025; 41(3) doi: 10.1097/MOG.0000000000001080
|
| 35 |
Tiew-Yik Ting, Wei-Jing Lee, Ahmad Bazli Ramzi, Hoe-Han Goh. Bioengineered Saccharomyces cerevisiae with neprosin for gluten detoxification. Journal of Future Foods 2026; 6(6) doi: 10.1016/j.jfutfo.2025.01.008
|
| 36 |
Sandip K. Wagh, Karen M. Lammers, Manohar V. Padul, Alfonso Rodriguez-Herrera, Veronica I. Dodero. Celiac Disease and Possible Dietary Interventions: From Enzymes and Probiotics to Postbiotics and Viruses. International Journal of Molecular Sciences 2022; 23(19) doi: 10.3390/ijms231911748
|
| 37 |
A James M Daveson, Richard Stubbs, Thomas M Polasek, Jorma Isola, Robert Anderson, Jason A Tye-Din, Mark Schoeman, Claudette Lionnet, Swee Lin Chen Yi Mei, Jelena Mihajlović, Martina Wirth, Evelyn Peelen, Amelie Schreieck, Hella Kohlhof, Daniel Vitt, Andreas Muehler, Franziska Buriánek. Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Gastroenterology & Hepatology 2025; 10(1) doi: 10.1016/S2468-1253(24)00248-6
|
| 38 |
A. Scricciolo, V. Lombardo, L. Elli, K.A. Bascuñán, L. Doneda, F. Rinaldi, D. Pinto, M. Araya, A. Costantino, M. Vecchi, L. Roncoroni. Use of a proline-specific endopeptidase to reintroduce gluten in patients with non-coeliac gluten sensitivity: A randomized trial. Clinical Nutrition 2022; 41(9) doi: 10.1016/j.clnu.2022.07.029
|
| 39 |
Diana Linke. Enzymatic prevention of health risks in food. Current Opinion in Food Science 2015; 1 doi: 10.1016/j.cofs.2014.09.004
|
| 40 |
Alberto Caminero, Heather J. Galipeau, Justin L. McCarville, Chad W. Johnston, Steve P. Bernier, Amy K. Russell, Jennifer Jury, Alexandra R. Herran, Javier Casqueiro, Jason A. Tye-Din, Michael G. Surette, Nathan A. Magarvey, Detlef Schuppan, Elena F. Verdu. Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity. Gastroenterology 2016; 151(4) doi: 10.1053/j.gastro.2016.06.041
|
| 41 |
Federico Manai, Marialaura Amadio. From gluten to therapeutics: molecular mechanisms of celiac disease and emerging alternatives to the gluten-free diet. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1900029
|
| 42 |
Oleg I. Klychnikov, Tatiana M. Shamorkina, Stephen D. Weeks, Hans C. van Leeuwen, Jeroen Corver, Jan W. Drijfhout, Peter A. van Veelen, Nikolai N. Sluchanko, Sergei V. Strelkov, Paul J. Hensbergen. Discovery of a new Pro-Pro endopeptidase, PPEP-2, provides mechanistic insights into the differences in substrate specificity within the PPEP family. Journal of Biological Chemistry 2018; 293(28) doi: 10.1074/jbc.RA118.003244
|
| 43 |
Maxim D'heedene, Tim Vanuytsel, Lucas Wauters. Celiac disease: Hope for new treatments beyond a gluten-free diet. Clinical Nutrition 2024; 43(6) doi: 10.1016/j.clnu.2024.04.014
|
| 44 |
Katri Kaukinen, Katri Lindfors. Novel Treatments for Celiac Disease: Glutenases and Beyond. Digestive Diseases 2015; 33(2) doi: 10.1159/000369536
|
| 45 |
Marco Valvano, Stefano Fabiani, Sabrina Monaco, Mauro Calabrò, Antonio Mancusi, Sara Frassino, Claudia Rolandi, Marta Mosca, Susanna Faenza, Emanuele Sgamma, Nicola Cesaro, Giovanni Latella. Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review. International Journal of Molecular Sciences 2023; 24(16) doi: 10.3390/ijms241612800
|
| 46 |
Valérie Abadie, Arnold S. Han, Bana Jabri, Ludvig M. Sollid. New Insights on Genes, Gluten, and Immunopathogenesis of Celiac Disease. Gastroenterology 2024; 167(1) doi: 10.1053/j.gastro.2024.03.042
|
| 47 |
Stefania Picascia, Roberta Mandile, Renata Auricchio, Riccardo Troncone, Carmen Gianfrani. Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications. Nutrients 2015; 7(12) doi: 10.3390/nu7125515
|
| 48 |
Peter D Mooney, Marios Hadjivassiliou, David S Sanders. Emerging drugs for coeliac disease. Expert Opinion on Emerging Drugs 2014; 19(4) doi: 10.1517/14728214.2014.959490
|
| 49 |
Shakira Yoosuf, Govind K. Makharia. Evolving Therapy for Celiac Disease. Frontiers in Pediatrics 2019; 7 doi: 10.3389/fped.2019.00193
|
| 50 |
Rakhi Panda, Katherine L. Fiedler, Chung Y. Cho, Raymond Cheng, Whitney L. Stutts, Lauren S. Jackson, Eric A. E. Garber. Effects of a Proline Endopeptidase on the Detection and Quantitation of Gluten by Antibody-Based Methods during the Fermentation of a Model Sorghum Beer. Journal of Agricultural and Food Chemistry 2015; 63(48) doi: 10.1021/acs.jafc.5b04205
|
| 51 |
W. J. Canestaro, T. C. Edwards, D. L. Patrick. Systematic review: patient‐reported outcome measures in coeliac disease for regulatory submissions. Alimentary Pharmacology & Therapeutics 2016; 44(4) doi: 10.1111/apt.13703
|
| 52 |
Guoxian Wei, Na Tian, Roland Siezen, Detlef Schuppan, Eva J. Helmerhorst. Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 311(3) doi: 10.1152/ajpgi.00185.2016
|
| 53 |
Karen M. Lammers, Maria G. Herrera, Veronica I. Dodero. Translational Chemistry Meets Gluten‐Related Disorders. ChemistryOpen 2018; 7(3) doi: 10.1002/open.201700197
|
| 54 |
Paolo D’Avino, Gloria Serena, Victoria Kenyon, Alessio Fasano. An updated overview on celiac disease: from immuno-pathogenesis and immuno-genetics to therapeutic implications. Expert Review of Clinical Immunology 2021; 17(3) doi: 10.1080/1744666X.2021.1880320
|
| 55 |
George Janssen, Chantal Christis, Yvonne Kooy-Winkelaar, Luppo Edens, Drew Smith, Peter van Veelen, Frits Koning, Karol Sestak. Ineffective Degradation of Immunogenic Gluten Epitopes by Currently Available Digestive Enzyme Supplements. PLOS ONE 2015; 10(6) doi: 10.1371/journal.pone.0128065
|
| 56 |
Brandon Sparks, Ivor Hill, Tracy Ediger. Going Beyond Gluten-Free: a Review of Potential Future Therapies for Celiac Disease. Current Treatment Options in Pediatrics 2021; 7(1) doi: 10.1007/s40746-020-00217-0
|
| 57 |
Marina Girbal-González, Francisco J. Pérez-Cano. Is There a Future Without Gluten Restrictions for Celiac Patients? Update on Current Treatments. Nutrients 2025; 17(18) doi: 10.3390/nu17182960
|
| 58 |
Guoxian Wei, Eva J. Helmerhorst, Ghassan Darwish, Gabriel Blumenkranz, Detlef Schuppan. Gluten Degrading Enzymes for Treatment of Celiac Disease. Nutrients 2020; 12(7) doi: 10.3390/nu12072095
|
| 59 |
Gloria Serena, Paolo D'Avino, Alessio Fasano. Celiac Disease and Non-celiac Wheat Sensitivity: State of Art of Non-dietary Therapies. Frontiers in Nutrition 2020; 7 doi: 10.3389/fnut.2020.00152
|
| 60 |
Sanskriti Varma, Suneeta Krishnareddy. Novel Drug Therapeutics in Celiac Disease: A Pipeline Review. Drugs 2022; 82(15) doi: 10.1007/s40265-022-01784-2
|
| 61 |
Manida Wungjiranirun, Ciaran P Kelly, Daniel A Leffler. Current Status of Celiac Disease Drug Development. American Journal of Gastroenterology 2016; 111(6) doi: 10.1038/ajg.2016.105
|
| 62 |
Bartosz Brzozowski. Impact of food processing and simulated gastrointestinal digestion on gliadin immunoreactivity in rolls. Journal of the Science of Food and Agriculture 2018; 98(9) doi: 10.1002/jsfa.8847
|
| 63 |
Mauro Bozzola, Federico Manai, Chiara Montalbano, Alberto Azzalin, Elena Bozzola, Alberto Villani, Sergio Comincini. Celiac Disease - From the Bench to the Clinic. 2019; doi: 10.5772/intechopen.80692
|
| 64 |
Sheila E. Crowe. Management of Celiac Disease: Beyond the Gluten-Free Diet. Gastroenterology 2014; 146(7) doi: 10.1053/j.gastro.2014.04.027
|
| 65 |
Charlene B. Van Buiten, Ryan J. Elias. Gliadin Sequestration as a Novel Therapy for Celiac Disease: A Prospective Application for Polyphenols. International Journal of Molecular Sciences 2021; 22(2) doi: 10.3390/ijms22020595
|
| 66 |
Eduardo Garcia-Calvo, Aina García-García, Santiago Rodríguez, Rosario Martín , Teresa García. Patologías relacionadas con el gluten: un auténtico desafío para la seguridad alimentaria.. Nutrición Clínica y Dietética Hospitalaria 2024; 44(4) doi: 10.12873/444garcia
|
| 67 |
Satya Kurada, Abhijeet Yadav, Daniel A. Leffler. Current and novel therapeutic strategies in celiac disease. Expert Review of Clinical Pharmacology 2016; 9(9) doi: 10.1080/17512433.2016.1200463
|
| 68 |
Karol Sestak, Hazel Thwin, Jason Dufour, Pyone Aye, David Liu, Charles Moehs. The Effects of Reduced Gluten Barley Diet on Humoral and Cell-Mediated Systemic Immune Responses of Gluten-Sensitive Rhesus Macaques. Nutrients 2015; 7(3) doi: 10.3390/nu7031657
|
| 69 |
Karol Sestak, Hazel Thwin, Jason Dufour, David Liu, Xavier Alvarez, David Laine, Adam Clarke, Anthony Doyle, Pyone Aye, James Blanchard, Charles Moehs. Supplementation of Reduced Gluten Barley Diet with Oral Prolyl Endopeptidase Effectively Abrogates Enteropathy-Associated Changes in Gluten-Sensitive Macaques. Nutrients 2016; 8(7) doi: 10.3390/nu8070401
|
| 70 |
Mariana Verdelho Machado. New Developments in Celiac Disease Treatment. International Journal of Molecular Sciences 2023; 24(2) doi: 10.3390/ijms24020945
|
| 71 |
James Haridy, Diana Lewis, Evan D. Newnham. Investigational drug therapies for coeliac disease – where to from here?. Expert Opinion on Investigational Drugs 2018; 27(3) doi: 10.1080/13543784.2018.1438407
|
| 72 |
Miguel Ribeiro, Fernando M. Nunes, Marta Rodriguez-Quijano, Jose Maria Carrillo, Gérard Branlard, Gilberto Igrejas. Next-generation therapies for celiac disease: The gluten-targeted approaches. Trends in Food Science & Technology 2018; 75 doi: 10.1016/j.tifs.2018.02.021
|
| 73 |
Deepak Chellan, Gaurav Muktesh, Kim Vaiphei, Neha Berry, Narendra Dhaka, Saroj Kant Sinha, Babu Ram Thapa, Rakesh Kochhar. Effect of gluten‐free diet and compliance on quality of life in pediatric celiac disease patients. JGH Open 2019; 3(5) doi: 10.1002/jgh3.12172
|
| 74 |
Bartosz Brzozowski, Katarzyna Stasiewicz, Mateusz Ostolski, Marek Adamczak. Reducing Immunoreactivity of Gliadins and Coeliac-Toxic Peptides Using Peptidases from L. acidophilus 5e2 and A. niger. Catalysts 2020; 10(8) doi: 10.3390/catal10080923
|
| 75 |
Alina Popp, Pilvi Laurikka, Diana Czika, Kalle Kurppa. The role of gluten challenge in the diagnosis of celiac disease: a review. Expert Review of Gastroenterology & Hepatology 2023; 17(7) doi: 10.1080/17474124.2023.2219893
|
| 76 |
Jürgen Stein, Detlef Schuppan. Coeliac Disease - New Pathophysiological Findings and Their Implications for Therapy. Visceral Medicine 2014; 30(3) doi: 10.1159/000365099
|
| 77 |
Jason A. Tye-Din, Heather J. Galipeau, Daniel Agardh. Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies. Frontiers in Pediatrics 2018; 6 doi: 10.3389/fped.2018.00350
|
| 78 |
Hiroki Ido, Hirotaka Matsubara, Manabu Kuroda, Akiko Takahashi, Yuzo Kojima, Satoshi Koikeda, Makoto Sasaki. Combination of Gluten-Digesting Enzymes Improved Symptoms of Non-Celiac Gluten Sensitivity: A Randomized Single-blind, Placebo-controlled Crossover Study. Clinical and Translational Gastroenterology 2018; 9(9) doi: 10.1038/s41424-018-0052-1
|
| 79 |
Daniel C Adelman, Joseph Murray, Tsung-Teh Wu, Markku Mäki, Peter H Green, Ciarán P Kelly. Measuring Change In Small Intestinal Histology In Patients With Celiac Disease. American Journal of Gastroenterology 2018; 113(3) doi: 10.1038/ajg.2017.480
|
| 80 |
Andrea Polo, Kashika Arora, Hana Ameur, Raffaella Di Cagno, Maria De Angelis, Marco Gobbetti. Gluten-free diet and gut microbiome. Journal of Cereal Science 2020; 95 doi: 10.1016/j.jcs.2020.103058
|
| 81 |
Rakhi Panda, Eric A. E. Garber. Detection and Quantitation of Gluten in Fermented-Hydrolyzed Foods by Antibody-Based Methods: Challenges, Progress, and a Potential Path Forward. Frontiers in Nutrition 2019; 6 doi: 10.3389/fnut.2019.00097
|
| 82 |
Michiel Akeroyd, Sylvie van Zandycke, Joost den Hartog, Jozé Mutsaers, Luppo Edens, Marco van den Berg, Chantal Christis. AN-PEP, Proline-Specific Endopeptidase, Degrades All Known Immunostimulatory Gluten Peptides in Beer Made from Barley Malt. Journal of the American Society of Brewing Chemists 2016; 74(2) doi: 10.1094/ASBCJ-2016-2300-01
|
| 83 |
Sara Massironi, Marianna Franchina, Alessandra Elvevi, Donatella Barisani. Beyond the gluten-free diet: Innovations in celiac disease therapeutics. World Journal of Gastroenterology 2024; 30(38): 4194-4210 doi: 10.3748/wjg.v30.i38.4194
|
| 84 |
Gregory John Tanner. Relative Rates of Gluten Digestion by Nine Commercial Dietary Digestive Supplements. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.784850
|
| 85 |
Peter H.R. Green, Benjamin Lebwohl, Ruby Greywoode. Celiac disease. Journal of Allergy and Clinical Immunology 2015; 135(5) doi: 10.1016/j.jaci.2015.01.044
|
| 86 |
R.M. Duar, K.J. Clark, P.B. Patil, C. Hernández, S. Brüning, T.E. Burkey, N. Madayiputhiya, S.L. Taylor, J. Walter. Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten. Journal of Applied Microbiology 2015; 118(2) doi: 10.1111/jam.12687
|
| 87 |
Julia König, Robert J. Brummer. Is an enzyme supplement for celiac disease finally on the cards?. Expert Review of Gastroenterology & Hepatology 2018; 12(6) doi: 10.1080/17474124.2018.1473762
|
| 88 |
Martial Rey, Menglin Yang, Linda Lee, Ye Zhang, Joey G. Sheff, Christoph W. Sensen, Hynek Mrazek, Petr Halada, Petr Man, Justin L McCarville, Elena F. Verdu, David C. Schriemer. Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease. Scientific Reports 2016; 6(1) doi: 10.1038/srep30980
|
| 89 |
Herbert Wieser, Peter Koehler, Katharina A. Scherf. Wheat - An Exceptional Crop. 2020; doi: 10.1016/B978-0-12-821715-3.00012-5
|
| 90 |
Giacomo Caio, Rachele Ciccocioppo, Giorgio Zoli, Roberto De Giorgio, Umberto Volta. Therapeutic options for coeliac disease: What else beyond gluten-free diet?. Digestive and Liver Disease 2020; 52(2) doi: 10.1016/j.dld.2019.11.010
|
| 91 |
Na Tian, Guoxian Wei, Detlef Schuppan, Eva J. Helmerhorst. Effect ofRothia mucilaginosaenzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014; 307(8) doi: 10.1152/ajpgi.00144.2014
|
| 92 |
B. N. Salden, V. Monserrat, F. J. Troost, M. J. Bruins, L. Edens, R. Bartholomé, G. R. Haenen, B. Winkens, F. Koning, A. A. Masclee. Randomised clinical study: Aspergillus niger‐derived enzyme digests gluten in the stomach of healthy volunteers. Alimentary Pharmacology & Therapeutics 2015; 42(3) doi: 10.1111/apt.13266
|
| 93 |
Katharina Anne Scherf, Herbert Wieser, Peter Koehler. Novel approaches for enzymatic gluten degradation to create high-quality gluten-free products. Food Research International 2018; 110 doi: 10.1016/j.foodres.2016.11.021
|
| 94 |
Warren M. Miner-Williams, Paul J. Moughan. Intestinal barrier dysfunction: implications for chronic inflammatory conditions of the bowel. Nutrition Research Reviews 2016; 29(1) doi: 10.1017/S0954422416000019
|
| 95 |
Jonas F Ludvigsson, Carolina Ciacci, Peter HR Green, Katri Kaukinen, Ilma R Korponay-Szabo, Kalle Kurppa, Joseph A Murray, Knut Erik Aslaksen Lundin, Markku J Maki, Alina Popp, Norelle R Reilly, Alfonso Rodriguez-Herrera, David S Sanders, Detlef Schuppan, Sarah Sleet, Juha Taavela, Kristin Voorhees, Marjorie M Walker, Daniel A Leffler. Outcome measures in coeliac disease trials: the Tampere recommendations. Gut 2018; 67(8) doi: 10.1136/gutjnl-2017-314853
|
| 96 |
Dimitris Kounatidis, Argyro Pavlou, Apostolos Evangelopoulos, Maria Psaroudaki, Evangelia Kotsi, Ioanna Petrakou, Panagiotis Paraskevopoulos, Vasileios Stamatopoulos, Eleni Mylona, Natalia G. Vallianou. Rethinking Celiac Disease Management: Treatment Approaches Beyond the Gluten-Free Diet. Biomedicines 2025; 14(1) doi: 10.3390/biomedicines14010029
|
| 97 |
Fatma Boukid, Mondher Mejri, Nicoletta Pellegrini, Stefano Sforza, Barbara Prandi. How Looking for Celiac‐Safe Wheat Can Influence Its Technological Properties. Comprehensive Reviews in Food Science and Food Safety 2017; 16(5) doi: 10.1111/1541-4337.12288
|
| 98 |
Gopal Veeraraghavan, Daniel A Leffler, Dharmesh H Kaswala, Rupa Mukherjee. Celiac disease 2015 update: new therapies. Expert Review of Gastroenterology & Hepatology 2015; 9(7) doi: 10.1586/17474124.2015.1033399
|
| 99 |
Claudia E. Osorio, Nuan Wen, Jaime H. Mejias, Bao Liu, Stephen Reinbothe, Diter von Wettstein, Sachin Rustgi. Development of wheat genotypes expressing a glutamine-specific endoprotease from barley and a prolyl endopeptidase from Flavobacterium meningosepticum or Pyrococcus furiosus as a potential remedy to celiac disease. Functional & Integrative Genomics 2019; 19(1) doi: 10.1007/s10142-018-0632-x
|
| 100 |
Erica Barr, Stephen Plogsted. PharmacotherapyFirst: A Multimedia Learning Resource. 2017; doi: 10.21019/pharmacotherapyfirst.celiac_overview
|
| 101 |
Maaike Bruins. The Clinical Response to Gluten Challenge: A Review of the Literature. Nutrients 2013; 5(11) doi: 10.3390/nu5114614
|
| 102 |
Gianfranco Mamone, Luigia Di Stasio, Serena Vitale, Stefania Picascia, Carmen Gianfrani. Analytical and functional approaches to assess the immunogenicity of gluten proteins. Frontiers in Nutrition 2023; 9 doi: 10.3389/fnut.2022.1049623
|
| 103 |
Liana Tsiatsiani, Michiel Akeroyd, Maurien Olsthoorn, Albert J. R. Heck.
Aspergillus niger Prolyl Endoprotease
for Hydrogen–Deuterium Exchange Mass Spectrometry and Protein
Structural Studies. Analytical Chemistry 2017; 89(15) doi: 10.1021/acs.analchem.7b01161
|
| 104 |
Juha Taavela, Keijo Viiri, Alina Popp, Mikko Oittinen, Valeriia Dotsenko, Markku Peräaho, Synnöve Staff, Jani Sarin, Francisco Leon, Markku Mäki, Jorma Isola. Histological, immunohistochemical and mRNA gene expression responses in coeliac disease patients challenged with gluten using PAXgene fixed paraffin-embedded duodenal biopsies. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1089-7
|
| 105 |
Martina Crepaldi, Michela Palo, Daria Maniero, Luisa Bertin, Edoardo Vincenzo Savarino, Robert P. Anderson, Fabiana Zingone. Emerging Pharmaceutical Therapies to Address the Inadequacy of a Gluten-Free Diet for Celiac Disease. Pharmaceuticals 2023; 17(1) doi: 10.3390/ph17010004
|
| 106 |
Gianfranco Mamone, Maria Cristina Comelli, Serena Vitale, Luigia Di Stasio, Katharina Kessler, Ilaria Mottola, Francesco Siano, Linda Cavaletti, Carmen Gianfrani. E40 glutenase detoxification capabilities of residual gluten immunogenic peptides in in vitro gastrointestinal digesta of food matrices made of soft and durum wheat. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.974771
|
| 107 |
Davide Scalvini, Chiara Scarcella, Giulia Mantica, Erica Bartolotta, Stiliano Maimaris, Erica Fazzino, Federico Biagi, Annalisa Schiepatti. Beyond gluten-free diet: a critical perspective on phase 2 trials on non-dietary pharmacological therapies for coeliac disease. Frontiers in Nutrition 2025; 11 doi: 10.3389/fnut.2024.1501817
|
| 108 |
Shakira Yoosuf, Amelie Therrien, Daniel A. Leffler. Coeliac Disease and Gluten-Related Disorders. 2022; doi: 10.1016/B978-0-12-821571-5.00011-8
|
| 109 |
Guoxian Wei, Na Tian, Adriana C Valery, Yi Zhong, Detlef Schuppan, Eva J Helmerhorst. Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease. American Journal of Gastroenterology 2015; 110(6) doi: 10.1038/ajg.2015.97
|
| 110 |
Henrik Toft-Hansen, Karina S. Rasmussen, Anne Staal, Erwin L. Roggen, Ludvig M. Sollid, Søren T. Lillevang, Torben Barington, Steffen Husby. Treatment of both native and deamidated gluten peptides with an endo-peptidase from Aspergillus niger prevents stimulation of gut-derived gluten-reactive T cells from either children or adults with celiac disease. Clinical Immunology 2014; 153(2) doi: 10.1016/j.clim.2014.05.009
|
| 111 |
Luis Vaquero, David Bernardo, Francisco León, Laura Rodríguez-Martín, Begoña Alvarez-Cuenllas, Santiago Vivas. Challenges to drug discovery for celiac disease and approaches to overcome them. Expert Opinion on Drug Discovery 2019; 14(10) doi: 10.1080/17460441.2019.1642321
|
| 112 |
Antonio Di Sabatino, Giovanni Santacroce, Paola Ilaria Bianchi, Nicola Aronico. Pediatric and Adult Celiac Disease. 2024; doi: 10.1016/B978-0-443-13359-6.00013-3
|
| 113 |
Laura Kivelä, Alberto Caminero, Daniel A. Leffler, Maria Ines Pinto-Sanchez, Jason A. Tye-Din, Katri Lindfors. Current and emerging therapies for coeliac disease. Nature Reviews Gastroenterology & Hepatology 2021; 18(3) doi: 10.1038/s41575-020-00378-1
|
| 114 |
Anmar AL-Taie, Amina Murodalieva, Maryam Abdullah, Nawaz Khoshnaw. Prospects of clinical trials for novel therapeutic approaches in celiac disease. Gastroenterology & Endoscopy 2025; 3(3) doi: 10.1016/j.gande.2025.05.007
|
| 115 |
K. Gottlieb, J. Dawson, F. Hussain, J. A. Murray. Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials. Gastroenterology Report 2015; 3(2) doi: 10.1093/gastro/gov006
|